Member Info for ratcliffewriter

'Scancell's success will be determined by what the drugs do in patients not who counts the beans.'

Which explains exactly why the appointment was received with equanimity. No big deal either way.

I'd far rather wonder why they don't shout good news louder, than have an upbeat RNS that on examination reveals nothing of any substance.

One has to trust that the graph at his last company was despite him rather than because of him. If it was because of him, I doubt Sclp would have employed him somehow.

Nom - It took 10 minutes.

To be fair Nomlungu, 10.6 percent does have a zero in it, and after 125:1 x 3 compression over the years, ten percent could be argued as being as near to zero as makes little difference in the world of Val accounting.

Could be a useful way of crystallising a loss to offset against a possible CGT liability elsewhere. Anyway, tomorrow is another day.

I doubt it's a dump per se - second 500k attracted a slightly higher price than the first, and the sp is weak at the moment so a 1 million dump would have hit it harder. Also the bid on smaller quantities rose after those transactions. But hey, who knows?!

Don't forget the needle-free delivery - LD was surprised at the number of people who had a deep fear of needles. Needle-free would be a big plus on top of efficacy etc.

73 percent of 87 is 63 or 64, depending which side of the decimal point you fall. Impressive.

Andysel you say 'the lab has its first contract, the official launch of the Lab is in September' - translates as 'the lab has one contract which expires in September.'

Beyond that, nothing. The launch is going to be a very quiet party as things stand.

Some usual suspects have been curiously (and pleasantly) absent since that last RNS, but I'm sure that's just coincidence. They must just have decided to have a couple of weeks off.

The difference is that if the lth here say anything like that, you get an invasion of 'balanced' posters screaming 'happy clapper', but when a 'chartist' says it it's seen as somehow informed. Nowt as que er as folk!

Zak Mir is about as reliable as an Austin Allegro, but we shall see.

Probably not.

Reminiscent of the David Carradine King Fu series. For 'crumbs' Read 'grasshopper.'

Meanwhile one can peruse the 'other side' and stand in moderate amazement at the cess pit of spite and bile being stirred around by some who would tell you they are 'balanced.' They seem to be missing an 'un', but then reality is subjective I suppose.

After 20 years, 'now undergoing pre-clinical research in the US'. Not exactly on the cusp of human trials.

Fat fingers!

The contract announced in mid july for the lab says 'This defined work programme involves a multi-stage project and is expected to complete at the end of September 2023.'

So any income from it will stop in 8 weeks maximum.

If ever the term 'DYOR' needed an illustration, that video is it.